Toll Brothers exits its Q2 earnings week with short sellers pulling back sharply — yet the stock is still down 8% on the week and trading near 15-month lows.
The most notable shift since the pre-earnings notes is in short interest itself. Bears covered hard on May 19: SI dropped 7.6% in a single session to 3.8% of the free float, reversing a chunk of the aggressive build that had pushed it to 4.2% the day before. On a week-on-week basis, the net change is now essentially flat at -0.4%. That's a meaningful change from the story told here two days ago, when shorts were at their most aggressive in months. The covering did not rescue the stock — TOL fell another 2.2% on Tuesday to close at $124.14, and the month-to-date loss stands at 15%.
The borrow market confirms there is no squeeze in play. Availability is extraordinarily loose — nearly 82x the current short interest, with roughly 93.6 million shares available to borrow versus the ~3.7 million currently shorted. The cost to borrow is just 0.35%, barely above last month's low. Bears who want to rebuild positions face no friction. The post-earnings covering looks like profit-taking, not a forced unwind.
Options positioning has normalised after the pre-earnings divergence. The put/call ratio is back near its 20-day average at 1.27, a z-score of just 0.17 — unremarkable by any measure, and well below the 52-week high of 1.33. The sharp drop to 1.07 flagged in last week's note, which marked near-record hedging optimism heading into the print, has unwound. Options traders are no longer sending a contrarian signal in either direction.
The Street remains cautious without being outright bearish. The consensus is a hold, with six analysts sitting on the fence. The mean price target of $168 implies around 35% upside from current levels — but that gap reflects the scale of the selloff more than renewed conviction. The most recent actions (all in April) ran in both directions: Truist maintained its Buy while cutting the target to $170, Evercore upgraded to Outperform with a $176 target, and Barclays is the house bear at Underweight with a $115 target that looks uncomfortably close to where the stock is trading. On valuation, the P/E has compressed to 9.3x and the P/B to 1.27x — both down materially over the past month as the price has fallen faster than estimates have moved. The EV/EBITDA at 7.3x is near multi-year lows for the name.
The peer picture underscores that TOL's slide is the worst in the group. DHI is down 6% on the week and TMHC off 5.3%, but CCS is the only name keeping pace with TOL's damage at -8.7%. PHM and MTH have held up relatively better, each down around 3% or less. The underperformance of the two luxury-skewed names — TOL and CCS — points to the affordability premium being repriced more aggressively than the volume builders.
The key data point to watch from here is whether the May 19 covering holds or reverses. With the earnings print now digested and borrow conditions remaining wide open, the question is whether the short interest trough has been set or whether bears reload at current levels.
See the live data behind this article on ORTEX.
Open TOL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
